These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16007524)

  • 1. The hepatotoxicity of antifungal medications in bone marrow transplant recipients.
    Fischer MA; Winkelmayer WC; Rubin RH; Avorn J
    Clin Infect Dis; 2005 Aug; 41(3):301-7. PubMed ID: 16007524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity associated with antifungal therapy after bone marrow transplantation.
    Wingard JR; Leather H
    Clin Infect Dis; 2005 Aug; 41(3):308-10. PubMed ID: 16007525
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
    Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
    Drew RH; Dodds Ashley E; Benjamin DK; Duane Davis R; Palmer SM; Perfect JR
    Transplantation; 2004 Jan; 77(2):232-7. PubMed ID: 14742987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
    Cagnoni PJ
    J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():81-6. PubMed ID: 11801587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
    Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE
    Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B-associated hyperbilirubinemia: case report and review of the literature.
    Olin JL; Spooner LM
    Pharmacotherapy; 2006 Jul; 26(7):1011-7. PubMed ID: 16878370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM; Seibel NL; Walsh TJ
    Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the current and future status of conventional amphotericin B?
    Kleinberg M
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():12-6. PubMed ID: 16707251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate.
    Garnacho-Montero J; Ortiz-Leyba C; García Garmendia JL; Jiménez Jiménez F
    Clin Infect Dis; 1998 Apr; 26(4):1016. PubMed ID: 9564508
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse drug reactions associated with the administration of amphotericin B lipid complex (Abelcet).
    Cook G; Franklin IM
    Bone Marrow Transplant; 1999 Jun; 23(12):1325-6. PubMed ID: 10414925
    [No Abstract]   [Full Text] [Related]  

  • 17. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
    Wade RL; Chaudhari P; Natoli JL; Taylor RJ; Nathanson BH; Horn DL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex.
    Ozaras R; Yemisen M; Mete B; Mert A; Ozturk R; Tabak F
    Mycoses; 2007 May; 50(3):242. PubMed ID: 17472626
    [No Abstract]   [Full Text] [Related]  

  • 19. Side-effects of amphotericin B lipid complex (Abelcet) in the Scandinavian population.
    Furebring M; Oberg G; Sjölin J
    Bone Marrow Transplant; 2000 Feb; 25(3):341-3. PubMed ID: 10673711
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.